© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
June 09, 2021
The vaccine is indicated to prevent invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.
June 02, 2021
The FDA approved Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis in children aged 6 years and older.
May 25, 2021
In a session from the PDS 2021 Virtual Super-Conference, experts discussed how POC testing capabilities enhance patient services and address antimicrobial resistance.
May 11, 2021
Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
April 22, 2021
This indication is approved under accelerated approval based on tumor response rate and durability of response.
April 16, 2021
Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.
March 22, 2021
AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks.
February 27, 2021
The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.
February 16, 2021
Novartis’ sacubitril/valsartan (Entresto) is now indicated for use in the treatment of chronic heart failure.
February 12, 2021
Belantamab mafodotin-blmf is now indicated for adult patients with relapsed or refractory myeloma who have received at least 4 prior therapies.